Company / Capital Expenditures
INSMED Inc Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$32.6M
FY2025
5-year range
$7.3M / $32.6M
FY2021-FY2025
Trend
+48.5%
vs FY2024
Sector context
#35 of 194
Health Care
What the data says
INSMED Inc's capital expenditures of $33M is higher than 82% of companies in the Health Care sector (FY2025). Capital Expenditures has increased for 5 consecutive years, from $6M in FY2020 to $33M in FY2025.
Based on SEC 10-K filings.
$33M in FY2025 with a 5-year CAGR of +39.2%. Top quartile in the Health Care sector.
Improved from $13M to $33M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +48.8%
- 5-Year CAGR
- +39.2%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 194This company $32.6M Sector average $117.5M
▼
-72.3% below sector average
Key checks
Key Insights
- INSMED Inc's capital expenditures has grown for 5 consecutive years.
- 5-year CAGR of +39.2%, indicating consistent growth.
- In FY2025, capital expenditures increased 48.5% year-over-year.
- Ranks #35 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.6M | +48.5% |
| FY2024 | $21.9M | +65.0% |
| FY2023 | $13.3M | +34.5% |
| FY2022 | $9.9M | +35.5% |
| FY2021 | $7.3M | +16.8% |
| FY2020 | $6.2M | -85.2% |
| FY2019 | $42.3M | +222.9% |
| FY2018 | $13.1M | +336.2% |
| FY2017 | $3.0M | -28.5% |
| FY2016 | $4.2M | +21.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026